Amy Fix

Shareholder
Brinks Gilson & Lione

With a career that has included in-house patent counsel positions with GlaxoSmithKline and Targacept, Inc. (now Catalyst Biosciences), Amy Fix understands the core business issues her pharmaceutical industry clients face. She has spent more than 16 years protecting pharmaceutical, agricultural, and polymer technologies, and is also a specialist in the growing sector of small-molecule drug development. Her clients range from large international pharmaceutical corporations to smaller companies producing innovative drugs and drug products.